Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensitivity and Specificity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in an Emergency Room Population

NCT00786708 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT00786708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00786708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensitivity and Specificity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in an Emergency Room Population
Lead sponsor
Columbia University
Phase
Observational
Overall status
Completed
Start date
December 31, 2006
Completion date
July 31, 2013
Enrollment
2,304 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

azotemia, hydronephrosis, renal failure, acute, renal insufficiency, chronic